Merck | MRK - Pre Tax Profit


Merck reported EUR869M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Adidas EUR 646M 550M Mar/2026
Adyen EUR 760.51M 127.03M Dec/2025
Akzo Nobel EUR 148M 598M Mar/2026
Alcon AG USD 240M 24M Mar/2026
Amadeus IT EUR 459.7M 133.3M Mar/2026
Amarin USD -852K 7.26M Dec/2025
AstraZeneca USD 4.81B 894M Jun/2026
BASF EUR 1.1B 25M Mar/2026
Bayer EUR 321M 2.67B Jun/2026
Beiersdorf EUR 408.5M 43.5M Jun/2025
Covestro EUR -353M 344M Dec/2025
Danone EUR 1.73B 133M Dec/2024
Fresenius EUR 535M 42M Jun/2026
Fresenius Medical Care EUR 383M 43M Jun/2026
Genmab DKK 295M 221M Jun/2026
Givaudan CHF 642M 292M Dec/2024
GlaxoSmithKline GBP 2.68B 532M Jun/2026
GRIFOLS EUR 247M 135M Jun/2026
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Infineon EUR 393M 55M Mar/2026
Lakefront Biotherapeutics EUR 13.96M 769.2M Mar/2026
Linde USD 2.43B 13M Mar/2026
Lonza CHF 624M 197M Dec/2024
Merck EUR 869M 468M Mar/2026
Novartis USD 4.27B 430M Jun/2026
Philips EUR 546M 356M Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
Sanofi EUR 837M 1.17B Jun/2026
UCB EUR 789M 427M Jun/2025